A novel 3-aryl-2-hydroxypropionic acid derivative, a process and intermediate for its manufacture, pharmaceutical preparations containing it and the use of the compound in clinical conditions associated with insulin resistance.

 
Web www.patentalert.com

< Substituted aryl-amine derivatives and methods of use

< Fused ring NK1 antagonists

> Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists

> Pyrazolonaphthyridine derivative
~ 00241